Hangzhou Tigermed Consulting Co., Ltd - ROE

The ROE as of September 2026 (TTM) for Hangzhou Tigermed Consulting Co., Ltd (3347.HK) is 0.44%

According to Hangzhou Tigermed Consulting Co., Ltd’s latest financial reports and current stock price. The company's current ROE is 0.44%. This represents a change of 645.79% compared to the average of 0.06% of the last 4 quarters.

Hangzhou Tigermed Consulting Co., Ltd (3347.HK) Historical ROE (quarterly & annually)

How has 3347.HK ROE performed in the past?

The mean historical ROE of Hangzhou Tigermed Consulting Co., Ltd over the last ten years is 11.01%. The current 0.44% ROE has changed -95.98% with respect to the historical average. Over the past ten years (40 quarters), 3347.HK's ROE was at its highest in in the June 2020 quarter at 14.34%. The ROE was at its lowest in in the June 2026 quarter at -2.37%.

Hangzhou Tigermed Consulting Co., Ltd (3347.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Hangzhou Tigermed Consulting Co., Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hangzhou Tigermed Consulting Co., Ltd (3347.HK) Average ROE

How has 3347.HK ROE performed in the past?

The current ROE of Hangzhou Tigermed Consulting Co., Ltd (3347.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hangzhou Tigermed Consulting Co., Ltd (3347.HK) ROE vs. Peers

How is 3347.HK’s ROE compared to its peers?

Hangzhou Tigermed Consulting Co., Ltd’s ROE is less than Pharmaron Beijing Co., Ltd. (10.96%), less than Sinopharm Group Co. Ltd. (8.33%), greater than XtalPi Holdings Ltd (-2.26%), less than RemeGen Co., Ltd. (128.12%), less than Joinn Laboratories(China)Co.,Ltd. (11.59%), less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (6.64%), less than Shanghai Pharmaceuticals Holding Co., Ltd (6.21%), less than WuXi XDC Cayman Inc (14.00%), less than Shanghai Henlius Biotech, Inc. (20.41%), greater than Shanghai Junshi Biosciences Co., Ltd. (-7.32%),

Build a custom stock screener for Hangzhou Tigermed Consulting Co., Ltd (3347.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hangzhou Tigermed Consulting Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hangzhou Tigermed Consulting Co., Ltd (3347.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hangzhou Tigermed Consulting Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.